熱門資訊> 正文
LAVA打算从纳斯达克退市
2025-11-13 21:51
- LAVA Therapeutics (LVTX) announced on Thursday that it has submitted written notice to Nasdaq of its intention to voluntarily delist its common shares from Nasdaq.
- The company also stated that 22.88M of the company’s common shares, representing approximately 87% of the company’s outstanding shares, were validly tendered and not withdrawn before the expiration of the initial offering period on November 12, 2025.
More on LAVA Therapeutics
- XOMA extends tender offer for LAVA Therapeutics to Oct 17
- Seeking Alpha’s Quant Rating on LAVA Therapeutics
- Historical earnings data for LAVA Therapeutics
- Financial information for LAVA Therapeutics
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
